JG
AGIO icon

Jain Global’s Agios Pharmaceuticals AGIO Stock Holding History

Jain Global’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.4M Buy
+91,647
New +$2.78M 0.01% 649
2025
Q3 		– Sell
-7,749
Closed -$258K – 987
2025
Q2 		$258K Buy
+7,749
New +$235K ﹤0.01% 925

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Jain Global's AGIO Position: Q2 2026 in Review

Jain Global opened a new position in Agios Pharmaceuticals (AGIO) in Q2 2026: 91,647 shares worth $3.4M. The stake represents 0.01% of the portfolio and ranks #649 among its holdings. This is a return to the name: Jain Global previously reported a position in AGIO as recently as Q2 2025.

Jain Global first reported a position in AGIO in Q2 2025 and has held it in 2 quarters since. 239 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Jain Global held 91,647 shares of Agios Pharmaceuticals worth $3.4M as of Q2 2026.
  • Agios Pharmaceuticals was a new Jain Global position in Q2 2026.
  • Agios Pharmaceuticals made up 0.01% of Jain Global's portfolio in Q2 2026, its #649 holding.
  • Jain Global first reported a position in Agios Pharmaceuticals in Q2 2025 and has held it in 2 quarters since.
  • 239 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.